DK0778023T3 - Produkt indeholdende rapamycin eller udvalgte derivater deraf og en NMDA- eller AMPA-antagonist til anvendelse ved behandling af epilepsi eller Huntingtons sygdom, og anvendelse af rapamycin eller udvalgte derivater deraf..... - Google Patents
Produkt indeholdende rapamycin eller udvalgte derivater deraf og en NMDA- eller AMPA-antagonist til anvendelse ved behandling af epilepsi eller Huntingtons sygdom, og anvendelse af rapamycin eller udvalgte derivater deraf.....Info
- Publication number
- DK0778023T3 DK0778023T3 DK96308786T DK96308786T DK0778023T3 DK 0778023 T3 DK0778023 T3 DK 0778023T3 DK 96308786 T DK96308786 T DK 96308786T DK 96308786 T DK96308786 T DK 96308786T DK 0778023 T3 DK0778023 T3 DK 0778023T3
- Authority
- DK
- Denmark
- Prior art keywords
- rapamycin
- selected derivatives
- nmda
- huntington
- epilepsy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US833795P | 1995-12-07 | 1995-12-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0778023T3 true DK0778023T3 (da) | 2003-06-30 |
Family
ID=21731060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96308786T DK0778023T3 (da) | 1995-12-07 | 1996-12-04 | Produkt indeholdende rapamycin eller udvalgte derivater deraf og en NMDA- eller AMPA-antagonist til anvendelse ved behandling af epilepsi eller Huntingtons sygdom, og anvendelse af rapamycin eller udvalgte derivater deraf..... |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0778023B1 (de) |
JP (1) | JPH09183727A (de) |
KR (1) | KR970032856A (de) |
CN (1) | CN1112925C (de) |
AR (1) | AR008747A1 (de) |
AT (1) | ATE234095T1 (de) |
AU (1) | AU700653B2 (de) |
BR (1) | BR9605895A (de) |
CA (1) | CA2192298A1 (de) |
CZ (2) | CZ6498A3 (de) |
DE (1) | DE69626610T2 (de) |
DK (1) | DK0778023T3 (de) |
ES (1) | ES2188730T3 (de) |
HU (1) | HUP9603370A3 (de) |
IL (1) | IL119778A (de) |
MX (1) | MX9606131A (de) |
NO (1) | NO309966B1 (de) |
NZ (1) | NZ299888A (de) |
PT (1) | PT778023E (de) |
SI (1) | SI0778023T1 (de) |
SK (1) | SK154796A3 (de) |
TW (1) | TW427904B (de) |
ZA (1) | ZA9610245B (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1002535A1 (de) | 1998-10-28 | 2000-05-24 | Hrissanthi Ikonomidou | Neue Verwendung von Glutamat-Antagonisten zur Behandlung von Krebs |
US7253169B2 (en) | 1999-11-12 | 2007-08-07 | Gliamed, Inc. | Aza compounds, pharmaceutical compositions and methods of use |
US6417189B1 (en) * | 1999-11-12 | 2002-07-09 | Gpi Nil Holdings, Inc. | AZA compounds, pharmaceutical compositions and methods of use |
FR2806626B1 (fr) * | 2000-03-22 | 2003-11-28 | Centre Nat Rech Scient | Utilisation de substances modulatrices de l'expression ou de la fonction d'une proteine impliquee dans le cycle cellulaire pour le traitement ou la prevention des lesions neurales aigues |
AU2001255406A1 (en) * | 2000-04-17 | 2001-10-30 | Gpi Nil Holdings, Inc. | Cyclic diaza compounds for treating neurodegenerative disorders |
GB0117645D0 (en) * | 2001-07-19 | 2001-09-12 | Isis Innovation | Therapeutic stratergies for prevention and treatment of alzheimers disease |
UA78529C2 (en) | 2001-10-10 | 2007-04-10 | Wyeth Corp | Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain |
US20030176455A1 (en) * | 2002-03-13 | 2003-09-18 | Wyeth | Method of inhibiting cell death |
PL1611144T3 (pl) | 2003-04-09 | 2011-03-31 | Wyeth Llc | Pochodne kwasu 2-(8,9-diokso-2,6-diazabicyklo(5.2.0)non-1(7)-en-2-ylo)alkilofosfonowego i ich zastosowanie jako antagonistów receptora N-metylo-D-asparaginianu (NMDA) |
AU2004229567A1 (en) * | 2003-04-09 | 2004-10-28 | Wyeth | Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1 (7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof |
US20070155771A1 (en) * | 2003-04-11 | 2007-07-05 | David Rubinsztein | Methods and means for treating protein conformational disorders |
US7485706B2 (en) * | 2003-07-30 | 2009-02-03 | The Board Of Trustees Of The Leland Stanford Junior University | Neurodegenerative protein aggregation inhibition methods and compounds |
TW200514775A (en) | 2003-10-22 | 2005-05-01 | Wyeth Corp | Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof |
ES2380779T3 (es) * | 2004-12-20 | 2012-05-18 | Wyeth Llc | Análogos de rapamicina y usos de los mismos en el tratamiento de trastornos neurológicos, proliferativos e inflamatorios |
CN101084226A (zh) | 2004-12-20 | 2007-12-05 | 惠氏公司 | 雷帕霉素衍生物及其治疗神经紊乱的用途 |
JP4857071B2 (ja) * | 2006-10-12 | 2012-01-18 | 潤平 笹部 | 筋萎縮性側策硬化症(als)の検出方法 |
EP2065038A1 (de) | 2007-11-30 | 2009-06-03 | Pharnext | Neue therapeutische Ansätze zur Behandlung der Charcot-Marie-Tooth Krankheit |
EP2135607A1 (de) | 2008-06-18 | 2009-12-23 | Pharnext | Kombination aus Pilocarpin und Methimazol zur Behandlung der Charcot-Marie-Tooth Krankheit und verwandten Erkrankungen |
CN104997774A (zh) * | 2009-04-10 | 2015-10-28 | 齐海燕 | 新的抗衰老试剂及其鉴别方法 |
EP2263665A1 (de) * | 2009-06-02 | 2010-12-22 | Pharnext | Neue Zusammensetzungen zur Behandlung von CMT und verwandten Erkrankungen |
US9393241B2 (en) | 2009-06-02 | 2016-07-19 | Pharnext | Compositions for treating CMT and related disorders |
EP2456437A4 (de) * | 2009-07-24 | 2013-01-09 | Inst Nat Rech Scient | Kombinationen aus curcumoiden- und mtor-hemmern für die behandlung von tauopathien |
US9283211B1 (en) | 2009-11-11 | 2016-03-15 | Rapamycin Holdings, Llc | Oral rapamycin preparation and use for stomatitis |
US9121859B2 (en) | 2012-12-04 | 2015-09-01 | Siemens Healthcare Diagnostics Inc. | Compounds and methods for determination of FKBP-binding immunosuppressant drugs |
AU2014276856B2 (en) | 2013-06-05 | 2018-11-15 | Pharnext | Stable oral solutions for combined API |
US9700544B2 (en) | 2013-12-31 | 2017-07-11 | Neal K Vail | Oral rapamycin nanoparticle preparations |
US10383870B2 (en) | 2016-06-10 | 2019-08-20 | Pharnext | Early treatment of CMT disease |
KR20200088856A (ko) * | 2017-11-15 | 2020-07-23 | 벤더르빌트 유니버시티 | 리소좀 기능의 개선 및 퇴행성 신경 질환의 치료를 위한 방법 및 조성물 |
CN114366738A (zh) * | 2021-12-20 | 2022-04-19 | 中国人民解放军军事科学院军事医学研究院 | 雷帕霉素在促进神经干细胞扩增中的用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206018A (en) * | 1978-11-03 | 1993-04-27 | Ayerst, Mckenna & Harrison, Inc. | Use of rapamycin in treatment of tumors |
JPH04230389A (ja) * | 1990-07-16 | 1992-08-19 | American Home Prod Corp | ラパマイシン誘導体 |
US5078999A (en) * | 1991-02-22 | 1992-01-07 | American Home Products Corporation | Method of treating systemic lupus erythematosus |
IL101353A0 (en) * | 1991-04-03 | 1992-11-15 | American Home Prod | Pharmaceutical compositions for treating diabetes |
DE4118740A1 (de) * | 1991-06-05 | 1992-12-10 | Schering Ag | Neue kombinationspraeparate zur behandlung des morbus parkinson |
ZA924953B (en) * | 1991-07-25 | 1993-04-28 | Univ Louisville Res Found | Method of treating ocular inflammation |
US5260299A (en) * | 1992-03-05 | 1993-11-09 | American Home Products Corporation | Rapamycin 42-sulfonates and 42-(N-Carboalkoxy)Sulfamates Useful as Immunosuppressive Agents |
IL111003A0 (en) * | 1993-09-30 | 1994-11-28 | American Home Prod | Multi-component oral rapamycin formulation |
-
1996
- 1996-11-28 TW TW085114700A patent/TW427904B/zh not_active IP Right Cessation
- 1996-12-04 CZ CZ9864A patent/CZ6498A3/cs unknown
- 1996-12-04 ES ES96308786T patent/ES2188730T3/es not_active Expired - Lifetime
- 1996-12-04 DE DE69626610T patent/DE69626610T2/de not_active Expired - Fee Related
- 1996-12-04 PT PT96308786T patent/PT778023E/pt unknown
- 1996-12-04 CZ CZ963544A patent/CZ354496A3/cs unknown
- 1996-12-04 DK DK96308786T patent/DK0778023T3/da active
- 1996-12-04 SI SI9630586T patent/SI0778023T1/xx unknown
- 1996-12-04 SK SK1547-96A patent/SK154796A3/sk unknown
- 1996-12-04 AT AT96308786T patent/ATE234095T1/de not_active IP Right Cessation
- 1996-12-04 EP EP96308786A patent/EP0778023B1/de not_active Expired - Lifetime
- 1996-12-05 AU AU74178/96A patent/AU700653B2/en not_active Ceased
- 1996-12-05 NZ NZ299888A patent/NZ299888A/en unknown
- 1996-12-05 ZA ZA9610245A patent/ZA9610245B/xx unknown
- 1996-12-05 KR KR1019960062011A patent/KR970032856A/ko not_active Application Discontinuation
- 1996-12-05 MX MX9606131A patent/MX9606131A/es unknown
- 1996-12-06 CA CA002192298A patent/CA2192298A1/en not_active Abandoned
- 1996-12-06 AR ARP960105543A patent/AR008747A1/es not_active Application Discontinuation
- 1996-12-06 JP JP8326582A patent/JPH09183727A/ja active Pending
- 1996-12-06 IL IL11977896A patent/IL119778A/xx not_active IP Right Cessation
- 1996-12-06 CN CN96123098A patent/CN1112925C/zh not_active Expired - Fee Related
- 1996-12-06 BR BR9605895A patent/BR9605895A/pt not_active Application Discontinuation
- 1996-12-06 HU HU9603370A patent/HUP9603370A3/hu unknown
- 1996-12-06 NO NO965238A patent/NO309966B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2188730T3 (es) | 2003-07-01 |
CZ6498A3 (cs) | 1998-06-17 |
DE69626610T2 (de) | 2003-10-02 |
AU7417896A (en) | 1997-06-12 |
NO309966B1 (no) | 2001-04-30 |
NO965238D0 (no) | 1996-12-06 |
HU9603370D0 (en) | 1997-01-28 |
EP0778023B1 (de) | 2003-03-12 |
EP0778023A1 (de) | 1997-06-11 |
IL119778A0 (en) | 1997-03-18 |
CZ354496A3 (cs) | 1998-03-18 |
PT778023E (pt) | 2003-06-30 |
BR9605895A (pt) | 1998-08-18 |
ATE234095T1 (de) | 2003-03-15 |
MX9606131A (es) | 1997-08-30 |
HUP9603370A2 (en) | 1997-05-28 |
ZA9610245B (en) | 1998-06-05 |
IL119778A (en) | 1999-07-14 |
NZ299888A (en) | 2001-02-23 |
DE69626610D1 (de) | 2003-04-17 |
TW427904B (en) | 2001-04-01 |
AU700653B2 (en) | 1999-01-14 |
SK154796A3 (en) | 1997-09-10 |
HUP9603370A3 (en) | 1998-12-28 |
KR970032856A (ko) | 1997-07-22 |
SI0778023T1 (en) | 2003-08-31 |
CN1159915A (zh) | 1997-09-24 |
CN1112925C (zh) | 2003-07-02 |
CA2192298A1 (en) | 1997-06-08 |
NO965238L (no) | 1997-06-09 |
JPH09183727A (ja) | 1997-07-15 |
AR008747A1 (es) | 2000-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0778023T3 (da) | Produkt indeholdende rapamycin eller udvalgte derivater deraf og en NMDA- eller AMPA-antagonist til anvendelse ved behandling af epilepsi eller Huntingtons sygdom, og anvendelse af rapamycin eller udvalgte derivater deraf..... | |
DE69626961T2 (de) | Wegwerfkleidungsstück, verfahren und vorrichtung zu dessen herstellung | |
DE69635023D1 (de) | Ulmwh (ultra-low-molecular weight heparin) zur behandlung von asthma | |
DE69629865D1 (de) | Intraluminale medische Vorrichtung, insbesondere Blutfilter | |
NL1000352C2 (nl) | Elektronisch betaalsysteem met verschillende rekeneenheden, elektronisch betaalmiddel alsmede werkwijze voor elektronisch betalen. | |
NL350032I1 (nl) | Pyrazool-4-yl-benzoylderivaten de toepassing ervan als herbiciden. | |
AU7419996A (en) | Device for removing toxic substances from the blood | |
NO902319D0 (no) | Fremgangsmaate for aa bestemme egenskaper vedroerende stroemingsdynamikk for flerfasestroemning. | |
DE69416470D1 (de) | Elektrophotographischer Toner, und Verfahren zu dessen Herstellung | |
FR2704458B1 (fr) | Ensemble de distribution de produit. | |
NO975987D0 (no) | 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater | |
NO981800L (no) | FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan | |
NO962434L (no) | Titanlegering, titanlegeringsgjenstand og fremgangsmåte for fremstilling av denne | |
EP0778267A4 (de) | Sulfonamid-derivate enthaltende insektizide, mitizide und nematizide | |
DK0815092T3 (da) | Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner | |
DE69601211D1 (de) | Lebensmittel und verfahren zu dessen herstellung | |
PT851865E (pt) | Derivados de 12h-dibenzo¬d,g|¬1,3|dioxina | |
DE69625174T2 (de) | Gleitteil und verfahren zu dessen herstellung | |
BR9709766A (pt) | Processo de preparação de 2,2'-(1-metil-1,2-etanodilideno)bis(hidrazina carboximidamida) | |
DE69300253D1 (de) | Sulfonamidderivate, Verfahren zu ihrer Herstellung und diese enthaltende Herbizide. | |
DE19681518T1 (de) | Nahrungsmittelprodukt und Verfahren zu dessen Herstellung | |
NO983492D0 (no) | 2,3-disubstituerte cyklopentanderivater, fremgangsmÕte for fremstilling derav, og medisinsk anvendelse derav | |
MA23936A1 (fr) | Dimaleate de n,n-diethyl-8, 8-dipropyl-2-azaspiro (4,5) decane -2-propanamine | |
DK0783491T3 (da) | Fremgangsmåde til fremstilling af 3,3,5-trichlorglutarimid | |
DE59610341D1 (de) | Verfahren zur Herstellung von 2,4,6-Trichlorpyrimidin |